Sample Header with Navigation Dropdowns
Sample Header with Navigation Dropdowns
Solutions Technology About
Profile Settings Logout
Solutions
Tele-Health Clinics Pharmacy Services Product & Cultivation
Technology
ScriptIT
Brands
Chemist Greenhouse 5Leaf Chronic Doctors CuratD Health
About

Alliance Healthcare Australia Appoints The Entourage Effect as Exclusive Distribution Partner for 5LEAF & first-line supplier to the Alliance Healthcare Australia Group of pharmacy members. 

Herston, QLD, – Alliance Healthcare Australia (AHA) is pleased to announce the appointment of The Entourage Effect as its first-line group supplier and exclusive distribution partner for 5LEAF, a leading brand in medicinal cannabis products. Additionally, The Entourage Effect has been appointed as the first-line supplier to the Alliance Group of pharmacy members. 

This strategic partnership marks a significant milestone for AHA as it enhances its distribution network and strengthens its commitment to providing high-quality medicinal cannabis solutions to healthcare providers across Australia. 

About 5LEAF: 5LEAF is a premium medicinal cannabis brand that focuses on delivering scientifically formulated products designed to support patient wellness and therapeutic outcomes. With a range of products tailored to various medical needs and the first indoor grown cultivation from Thailand, 5LEAF is at the forefront of the rapidly growing medicinal cannabis industry. 

Key Highlights of the Partnership: 

  • Exclusive Distribution: The Entourage Effect will serve as the exclusive distributor of 5LEAF products, ensuring seamless supply and distribution to pharmacies and healthcare providers across the nation. 
  • First-Line Supplier: The Entourage Effect is also appointed as the first-line supplier to the Alliance Group of pharmacy members, facilitating enhanced access to 5LEAF products. 
  • Enhanced Access: This partnership will enhance the availability of 5LEAF’s medicinal cannabis products, making them more accessible to patients who require high-quality therapeutic options. 
  • Strategic Alignment: The collaboration between Alliance Healthcare Australia and The Entourage Effect aligns with AHA’s mission to deliver innovative healthcare solutions through strategic partnerships and distribution excellence. 

Quotes: “We are excited to partner with The Entourage Effect as our exclusive distribution partner for 5LEAF and as the first-line supplier to our pharmacy group members. Their expertise and dedication to the medicinal cannabis sector make them the ideal partner to expand the reach of 5LEAF products,” said Brendon Rose CEO of Alliance Healthcare Australia. “This partnership will ensure that patients across Australia have greater access to the high-quality medicinal cannabis products they need.” 

“We are honoured to be appointed as the exclusive distribution partner for 5LEAF and as the first-line supplier to Alliance Healthcare Australia. This partnership reflects our shared commitment to advancing patient care and providing top-tier medicinal cannabis solutions,” said Lisa Varley CEO of The Entourage Effect. 

About Alliance Healthcare Australia: Alliance Healthcare Australia (AHA) is a leading provider of healthcare support services, including access to discounts, rebates, marketing support, and operational tools for group members. AHA specialises in integrating medicinal cannabis into traditional pharmacy settings, empowering healthcare providers to deliver comprehensive patient care. 

About The Entourage Effect: The Entourage Effect is a recognised leader in the distribution of medicinal cannabis products, known for its commitment to quality, compliance, and customer service. With a robust distribution network and deep industry knowledge, The Entourage Effect is dedicated to ensuring patients have access to the therapeutic benefits of cannabis. 

Media Contact:  

Rachel Swiatkiewicz 
Rachel@alliancehealthcare.com.au 

NEWS

Alliance Healthcare Australia Appoints The Entourage Effect as Exclusive Distribution Partner.

August 23, 2024

Herston, QLD, – Alliance Healthcare Australia (AHA) is pleased to announce the appointment of The Entourage Effect as its first-line group supplier and exclusive distribution partner for 5LEAF, a leading brand in medicinal cannabis products. Additionally, The Entourage Effect has been appointed as the first-line supplier to the Alliance Group of pharmacy members. 

This strategic partnership marks a significant milestone for AHA as it enhances its distribution network and strengthens its commitment to providing high-quality medicinal cannabis solutions to healthcare providers across Australia. 

About 5LEAF: 5LEAF is a premium medicinal cannabis brand that focuses on delivering scientifically formulated products designed to support patient wellness and therapeutic outcomes. With a range of products tailored to various medical needs and the first indoor grown cultivation from Thailand, 5LEAF is at the forefront of the rapidly growing medicinal cannabis industry. 

Key Highlights of the Partnership: 

  • Exclusive Distribution: The Entourage Effect will serve as the exclusive distributor of 5LEAF products, ensuring seamless supply and distribution to pharmacies and healthcare providers across the nation. 
  • First-Line Supplier: The Entourage Effect is also appointed as the first-line supplier to the Alliance Group of pharmacy members, facilitating enhanced access to 5LEAF products. 
  • Enhanced Access: This partnership will enhance the availability of 5LEAF’s medicinal cannabis products, making them more accessible to patients who require high-quality therapeutic options. 
  • Strategic Alignment: The collaboration between Alliance Healthcare Australia and The Entourage Effect aligns with AHA’s mission to deliver innovative healthcare solutions through strategic partnerships and distribution excellence. 

Quotes: “We are excited to partner with The Entourage Effect as our exclusive distribution partner for 5LEAF and as the first-line supplier to our pharmacy group members. Their expertise and dedication to the medicinal cannabis sector make them the ideal partner to expand the reach of 5LEAF products,” said Brendon Rose CEO of Alliance Healthcare Australia. “This partnership will ensure that patients across Australia have greater access to the high-quality medicinal cannabis products they need.” 

“We are honoured to be appointed as the exclusive distribution partner for 5LEAF and as the first-line supplier to Alliance Healthcare Australia. This partnership reflects our shared commitment to advancing patient care and providing top-tier medicinal cannabis solutions,” said Lisa Varley CEO of The Entourage Effect. 

About Alliance Healthcare Australia: Alliance Healthcare Australia (AHA) is a leading provider of healthcare support services, including access to discounts, rebates, marketing support, and operational tools for group members. AHA specialises in integrating medicinal cannabis into traditional pharmacy settings, empowering healthcare providers to deliver comprehensive patient care. 

About The Entourage Effect: The Entourage Effect is a recognised leader in the distribution of medicinal cannabis products, known for its commitment to quality, compliance, and customer service. With a robust distribution network and deep industry knowledge, The Entourage Effect is dedicated to ensuring patients have access to the therapeutic benefits of cannabis. 

Media Contact:  

Rachel Swiatkiewicz 
Rachel@alliancehealthcare.com.au 

 

Stay in the Know

Subscribe to our newsletter for the latest resources straight to your inbox!

Related Content

Alliance Healthcare Australia Launches Premium Medical Cannabis Products: 5 LEAF NORTH and 5LEAF SOUTH.

Related Content

Biolife Group Secures 20% Stake in AHA Corporate, Strengthening Cannabis Healthcare Integration Alliance

Innovators in Healthcare

GENERAL INQUIRY

MEMBER SUPPORT

QUICK LINKS

Privacy Policy Modal
Footer Example

Privacy Policy.

At Alliance Healthcare Australia, we are committed to protecting your privacy and ensuring that your personal information is handled in a safe and responsible manner. This policy outlines how we collect, use, hold, and disclose your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles (APPs).

  1. About Us

Alliance Healthcare Australia ABN 14 668 671 083 provides services including:

  • Access to discounts and rebates related to the purchase of pharmaceutical and other products.
  • Marketing support, including for clinics run by pharmacies under the AHA Corporate brands.
  • Access to purchasing technology systems.
  • Business analytics and operational support to group members.
  1. Collection of Personal Information

We collect personal information necessary to provide our services effectively. This may include:

  • Contact Details: Such as your name, address, phone number, and email address.
  • Health Information: Including details of your medical history and medications, where relevant.
  • Financial Information: Such as credit card details and bank account information for payment purposes.
  • Business Information: Information related to your use of our purchasing technology systems and other operational support services.
  1. Use of Personal Information

Your personal information is used to:

  • Provide and manage the services we offer, including processing discounts, rebates, and providing business analytics.
  • Communicate with you regarding our services, updates, and other relevant information.
  • Comply with legal obligations, such as reporting requirements under applicable laws.
  • Improve our services by analysing data and customer feedback.
  1. Holding of Personal Information

We take reasonable steps to protect your personal information from misuse, interference, loss, unauthorized access, modification, or disclosure. Information is stored securely and retained only for as long as necessary to fulfill the purposes for which it was collected, or as required by law.

  1. Disclosure of Personal Information

We may disclose your personal information to third parties, including:

  • Service Providers: Who assist us in providing our services, such as IT and marketing support providers.
  • Business Partners: Involved in the delivery of services, such as pharmacies and healthcare professionals.
  • Legal Authorities: When required by law or to protect our legal rights.
  • With Your Consent: Where you have expressly agreed to the disclosure.
  1. Access to and Correction of Personal Information

You have the right to access the personal information we hold about you and request corrections if needed. To do so, please contact us using the details provided below. We will respond to your request within a reasonable timeframe.

  1. Complaints and Contact Information

If you have any complaints or concerns about how we handle your personal information, or if you wish to access or correct your information, please contact us at:

Alliance Healthcare Australia
7 Butterfield Street, Herston QLD 4006
info@alliancehealthcare.com.au

We will investigate your complaint and respond promptly. If you are not satisfied with our response, you may escalate your complaint to the Office of the Australian Information Commissioner (OAIC).

  1. Changes to this Privacy Policy

We may update this Privacy Policy periodically to reflect changes in our practices or legal obligations. Any updates will be posted on our website, and we encourage you to review this policy regularly.

This Privacy Policy was last updated on 16th August 2024